Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future costs in cost effectiveness analysis.

Robert H Lee1

  • 1Department of Health Policy and Management, School of Medicine, University of Kansas, Mail Stop 3044, 3901 Rainbow Boulevard, Kansas City, KS 66160, United States.

Journal of Health Economics
|January 19, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel G13-RAPGEF2-RAP1 signaling pathway critical for platelet adhesion and aggregation.

Blood·2026
Same author

The fibrinogen αC region promotes arterial thrombosis in the context of hypofibrinogenemia.

Blood·2026
Same author

RAP1-RHO small GTPase cross-talk mediates integrin-dependent and -independent platelet procoagulant response.

Haematologica·2026
Same author

Platelet-mediated activation of perivascular mast cells triggers progression of sepsis to septic shock in mice.

Nature communications·2025
Same author

RAP1-RHO small GTPase cross-talk mediates integrin-dependent and -independent platelet procoagulant response.

bioRxiv : the preprint server for biology·2025
Same author

Lack of overt bleeding or platelet dysfunction in a mouse model of vascular Ehlers-Danlos syndrome.

Journal of thrombosis and haemostasis : JTH·2025
Same journal

Competition matters: Uniform vs. indication-based pricing of pharmaceuticals.

Journal of health economics·2026
Same journal

Integrating equity and productivity in health evaluation.

Journal of health economics·2026
Same journal

Income and immunity: The consequences of social security administration reform for childhood infection risk.

Journal of health economics·2026
Same journal

When fewer children mean shorter lives: Fertility policy and elderly well-being in China.

Journal of health economics·2026
Same journal

Health dynamics and reporting bias at retirement: An analysis using high-frequency data.

Journal of health economics·2026
Same journal

Intertemporal coordination in volunteer markets.

Journal of health economics·2026
See all related articles

This study clarifies cost-effectiveness analysis (CEA) by demonstrating that unrelated future costs distort decision-making, while related costs should be included. CEA should follow Garber and Phelps

Area of Science:

  • Health Economics
  • Medical Decision Making
  • Public Health Policy

Background:

  • Cost-effectiveness analysis (CEA) is a critical tool for healthcare resource allocation.
  • Existing literature presents conflicting views on the inclusion of future costs in CEA.
  • Generalizing prior work by Garber and Phelps (1997) provides a foundation for resolving these controversies.

Purpose of the Study:

  • To resolve controversies regarding the treatment of future costs in cost-effectiveness analysis (CEA).
  • To demonstrate how accounting for unrelated future costs can distort decision-making in CEA.
  • To clarify the appropriate inclusion of related future costs within CEA frameworks.

Main Methods:

  • Replication of Meltzer's (1997) analysis on accounting for future costs in medical CEA.

Related Experiment Videos

  • Generalization of the economic foundations of CEA as established by Garber and Phelps (1997).
  • Modeling analysis to evaluate the impact of different cost accounting methods on decision outcomes.

    • Main Results:

    • Accounting for unrelated future costs in CEA leads to distorted decision-making.
    • Meltzer's (1997) conclusion to include unrelated future costs stems from a problematic annuity model of the budget constraint.
    • Related future costs should be included in CEA across various models, including health maximization frameworks.

    Conclusions:

    • CEA should exclude unrelated future costs to avoid decision distortions.
    • Related future costs are essential components for accurate CEA.
    • The methodology recommended by Garber and Phelps (1997) provides the appropriate framework for cost treatment in CEA.